Januvia – Sitagliptin Tablets for Type 2 Diabetes Control
Januvia helps adults manage type 2 diabetes by regulating blood glucose levels. This DPP-4 inhibitor increases the body’s natural ability to lower elevated blood sugar. Patients achieve improved fasting and post-meal glucose control, reduced HbA1c, and enhanced daily energy levels.
Doctors prescribe Januvia for adults who cannot achieve target glucose levels with diet and exercise alone. Patients take Januvia orally once daily with or without food. Its convenient tablet form supports adherence and simplifies daily routines. Healthcare providers monitor patient glucose regularly to ensure optimal dosing and effective management.
Januvia works by enhancing the incretin system. It increases insulin release after meals and decreases glucagon production. Patients benefit from steady glucose control throughout the day without frequent hypoglycemia episodes. The therapy supports combination treatment with metformin, sulfonylureas, or insulin depending on patient needs. Patients report improved energy, stable appetite, and better overall quality of life while using Januvia.
Clinical studies show Januvia significantly reduces HbA1c and maintains glycemic control over long-term use. Doctors value its predictable effect and minimal gastrointestinal side effects compared to other oral antidiabetic drugs. Patients gain confidence from a simple daily regimen that integrates seamlessly into their lifestyle.
Januvia comes in oral tablets in multiple strengths to allow precise dosing. Patients can adjust therapy under medical supervision to maintain effective glucose control. Its formulation emphasizes reliability, ease of use, and patient convenience. Januvia empowers patients to take active control of their type 2 diabetes while supporting long-term health outcomes.
Product Specifications
| Specification | Details |
|---|---|
| Active Ingredient | Sitagliptin |
| Formulation | Oral tablet |
| Strength | 25 mg, 50 mg, 100 mg |
| Dosage Form | Oral, once daily |
| Indication | Type 2 diabetes mellitus in adults |
| Administration | Oral, with or without food |
| Mechanism of Action | DPP-4 inhibitor; increases insulin release, decreases glucagon |
| Duration of Action | 24 hours |
| Storage Conditions | Store at 20–25°C, protect from moisture |
| Common Side Effects | Upper respiratory infection, headache, mild gastrointestinal discomfort |
| Prescription Requirement | Prescription only |
Januvia enables patients to manage type 2 diabetes effectively. Its oral convenience, reliable glycemic control, and favorable safety profile make it a cornerstone in modern diabetes care.
Reviews
There are no reviews yet.